Source: ERS Lung Science Conference 2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Gizem Gunes (Munich, Germany). The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury. ERS Lung Science Conference 2017

Member's Comments

No comment yet.

Related content which might interest you: LSC - 2017 - The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases Year: 2017 The role of chronic inflammation in mouse lung tumourigenesis Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection Year: 2005 The pathomechanistic role of autophagy in lung fibrosis Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways Year: 2017 The role of mitochondrial DAMPs in driving lung inflammation and injury Source: International Congress 2016 – Dysfunctional mitochondria in respiratory disease Year: 2016 The role of pre-receptor glucocorticoid metabolism in regulating the severity and persistence of murine lung injury Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma Source: Eur Respir J, 55 (4) 1901340; 10.1183/13993003.01340-2019 Year: 2020 A role for WNT-5B in airway remodeling in COPD by activation of TGF-beta/Smad3 signaling? Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021 P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 The potential of epigenetic editing in chronic lung disease Source: International Congress 2018 – Organoids and pluripotent stem cells Year: 2018 The role of regulator and effector T lymphocytes in chronic obstructive pulmonary disease and lung cancer Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 The lung epithelial clock and its role in lung inflammation Source: International Congress 2017 – The circadian molecular clock in respiratory diseases and associated interventions Year: 2017 The role of infections as a trigger of COPD exacerbations and decline of lung function Source: Annual Congress 2011 - Epidemiology of COPD exacerbations Year: 2011 Targeting the mTOR signaling pathway to inhibit lung cell senescence in chronic obstructive pulmonary disease (COPD) Source: ERS Lung Science Conference 2017 Year: 2017 Low telomerase expression in alveolar epithelial plays a role in the pathogenesis of idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 The central role of CFTR in lung disease Source: International Congress 2016 – What can respiratory medicine learn from cystic fibrosis research? Year: 2016 Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021 Year: 2021